Dan Burgess logo

Dan Burgess

North America, Massachusetts, United States, Boston

Description

Daniel Burgess joined SV Life Sciences as a Venture Partner in 2014. Prior to joining SV, Mr. Burgess was founder, President and CEO of ...

Investor Profile

Dan Burgess has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dan Burgess frequently co-invest with?

SG
North America, Massachusetts, United States, Stoneham
Co-Investments: 1
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Baxter International
North America, Illinois, United States, Deerfield
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Polaris Venture Capital
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Novo Ventures
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 1
Ascension Ventures
North America, Missouri, United States, Clarkton
Co-Investments: 1

What are some of recent deals done by Dan Burgess?

PanOptica

Mount Arlington, New Jersey, United States

PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.

BiopharmaBiotechnologyTherapeutics
Series BApr 15, 2014
Amount Raised: $45,000,000
Ocular Therapeutix

Bedford, Massachusetts, United States

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

BiotechnologyHealth CareMedical Device
Series DJun 10, 2013
Amount Raised: $23,800,000